# Wuhan Biocause Pharmaceutical Development Co., Ltd., Wuhan, China – FDA Inspections

Source: https://www.keypedia.com/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb

> Inspection records and compliance data for Wuhan Biocause Pharmaceutical Development Co., Ltd. in Wuhan. 5 FDA inspections on record, 2 Form 483s, last inspected March 14, 2025.

---

## Details

- Name: Wuhan Biocause Pharmaceutical Development Co., Ltd.
- FEI Number: 3004202226
- Business Operations: API MANUFACTURE
- Address Line 1: Bldg. 1, 4th Floor, Zhuankou Economic Development, Hi-Tech Industrial Park
- City: Wuhan
- Country Name: China
- Address: Bldg. 1, 4th Floor, Zhuankou Economic Development, Hi-Tech Industrial Park, Wuhan, China
- Country: China

## Related Documents

- [FDA Inspection 1267912 - Wuhan Biocause Pharmaceutical Development Co., Ltd. - 2025-03-14](https://www.keypedia.com/records/fda_inspections/wuhan-biocause-pharmaceutical-development-co-ltd/cf0802f0-fbd5-4ef6-8a2f-51da576523d8) — source: FDA, date: March 14, 2025
- FDA Inspection 1267912 - Wuhan Biocause Pharmaceutical Development Co., Ltd. - 2025-03-14 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 14, 2025
- [483 - Wuhan Biocause Pharmaceutical Development Co., Ltd. - 2018-08-24](https://www.keypedia.com/records/483/wuhan-biocause-pharmaceutical-development-co-ltd/00961f58-1938-46fe-8a7e-658b59b98e37) — source: FDA, date: August 24, 2018
- [FDA Inspection 1069379 - Wuhan Biocause Pharmaceutical Development Co., Ltd. - 2018-08-24](https://www.keypedia.com/records/fda_inspections/wuhan-biocause-pharmaceutical-development-co-ltd/58c8650e-e596-4fd1-a0ef-b54e39889c78) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 24, 2018
- FDA Inspection 982641 - Wuhan Biocause Pharmaceutical Development Co., Ltd. - 2016-07-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 22, 2016
- FDA Inspection 873586 - Wuhan Biocause Pharmaceutical Development Co., Ltd. - 2014-02-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 28, 2014
- FDA Inspection 680329 - Wuhan Biocause Pharmaceutical Development Co., Ltd. - 2010-07-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 23, 2010

## Related Companies

- [Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)](https://www.keypedia.com/companies/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/13be9174-238f-43cf-bdf4-0c57cc0b0bc2)
- [Jiangxi Synergy Pharmaceutical, Co., Ltd.](https://www.keypedia.com/companies/jiangxi-synergy-pharmaceutical-co-ltd/9602f29a-9a10-4201-966c-b89b6a2d3ae5)
- [Zhejiang Cheng Yi Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-cheng-yi-pharmaceutical-co-ltd/dabc68a0-9969-418a-9cd6-54e9987ed8df)
- [Harman Finochem Limited](https://www.keypedia.com/companies/harman-finochem-limited/7622941a-bad2-45c3-bd91-07d2bb63f905)
- [Natco Pharma Ltd. - Chemical Division](https://www.keypedia.com/companies/natco-pharma-ltd-chemical-division/3d56c2ac-4a7d-4f9f-8987-966d0ff5e5f1)
- [Somerville Acquisitions, Inc.](https://www.keypedia.com/companies/somerville-acquisitions-inc/195f0557-96af-4562-98e7-9e03150b33cb)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/042118cf-4e9b-432b-b155-94c2b5e3e025)
- [Zach System S.A.](https://www.keypedia.com/companies/zach-system-sa/c663917a-2b9d-4375-bc79-2cdd0e280002)
- [Aarti Pharmalabs Limited](https://www.keypedia.com/companies/aarti-pharmalabs-limited/94a0adf3-5840-4cc1-9582-8eafd52d498e)
- [Arch Pharmalabs Ltd.](https://www.keypedia.com/companies/arch-pharmalabs-ltd/2766781c-7a1a-4718-bb0e-04fa9616a574)

## Related Officers

- [Tiara N Brown-Crosen](https://www.keypedia.com/people/tiara-n-brown-crosen/8255649d-25a9-49fa-a28d-0cdda922c0c3)
